Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Moderna Inc. buy Traumtanz

Moderna Inc.
Start price
€33.80
05.04.20 / 50%
Target price
€40.00
09.04.20
Performance (%)
-12.68%
End price
€29.52
09.04.20
Summary
This prediction ended on 09.04.20 with a price of €29.52. The price of Moderna Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -12.68%. Traumtanz has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Moderna Inc. 5.326% 5.326% -28.054% -85.915%
iShares Core DAX® 1.732% 4.638% 21.634% 71.886%
iShares Nasdaq 100 3.304% 0.517% 5.422% 113.046%
iShares Nikkei 225® 2.342% 0.972% 15.333% 47.267%
iShares S&P 500 2.357% 0.872% 3.125% 68.687%

According to Traumtanz what are the pros and cons of Moderna Inc. for the foreseeable future?

Pros
Cons
Few uniques
Dependend from some customers or products
Growths slower than the competition
Sustainability is little important
high free float
Higher risks for its business
Below average Marketposition
Significant cyclical dependencies
Business model of the past or high risk
Revenue decline/stagnation expected
EBIT decline/stagnation expected
High valuation
Low dividend yield expected
negative Cash Flow expected
Bad rating
Little Investments for future growth
ROE lower than 10% per year
Probably not worthwhile Investment
Little innovation
Little known brand

Comments by Traumtanz for this prediction

In the thread Moderna Inc. diskutieren
Prediction Buy
Perf. (%) -12.68%
Target price 40.000
Change
Ends at 09.04.20

Buy mit Kursziel 40,0

Traumtanz 
0
Report Share
05.04.20

ein vielversprechender Chart einer jungen Aktie:
https://en.wikipedia.org/wiki/Moderna
...In January 2020, Moderna announced development of a vaccine to inhibit COVID-19 coronavirus, in competition with other biotechnology companies, such as Gilead Sciences, Vaxart, Inovio Pharmaceuticals, and Novavax. In March 2020, the Phase I human study of the vaccine candidate began in partnership with the US National Institute of Allergy and Infectious Diseases.

Traumtanz 
2
Report Share
05.04.20 Buy -12.68%

https://www.onvista.de/aktien/MODERNA-INC-Aktie-US60770K1079

aber Vorsicht mit der Euphorie von diesen Kriegsgewinnlern...man weiss noch nicht, wer sich hier durchsetzten wird....wenn überhaupt!

Traumtanz 
2
Report Share
05.04.20 Buy -12.68%
In the thread Trading Moderna Inc.
Prediction Buy
Perf. (%) -12.68%
Target price 40.000
Change
Ends at 09.04.20

Buy beendet

Traumtanz 
0
Report Share
09.04.20

Stopped prediction by Traumtanz for Moderna Inc.

sell
Moderna Inc.

Start price
Target price
Perf. (%)
€40.03
26.11.24
€39.00
26.11.25
2.09%
27.11.24

Few uniques
Dependend from some customers or products
Growths slower than the competition
Sustainability is little important
Traumtanz 
26.11.24 50%
buy
Moderna Inc.

Start price
Target price
Perf. (%)
€37.58
18.11.24
€39.00
18.11.25
3.93%
22.11.24

Normal challenges to pay loans and raise capital
Innovative
Some uniques
Differentiated customer and product portfolio
Traumtanz 
18.11.24 50%
buy
Moderna Inc.

Start price
Target price
Perf. (%)
€35.39
18.11.24
€36.00
18.11.25
6.19%
18.11.24

Normal challenges to pay loans and raise capital
Innovative
Some uniques
Differentiated customer and product portfolio
Traumtanz 
18.11.24 50%
buy
Moderna Inc.

Start price
Target price
Perf. (%)
€73.21
02.12.23
€74.00
02.12.24
15.01%
14.12.23

Normal challenges to pay loans and raise capital
Innovative
Some uniques
Differentiated customer and product portfolio
Traumtanz 
02.12.23 50%
sell
Moderna Inc.

Start price
Target price
Perf. (%)
€71.59
24.11.23
€70.00
24.11.24
2.26%
02.12.23

Normal challenges to pay loans and raise capital
Innovative
Some uniques
Differentiated customer and product portfolio
Traumtanz 
24.11.23 50%
buy
Moderna Inc.

Start price
Target price
Perf. (%)
€70.95
23.11.23
€74.00
23.11.24
0.90%
24.11.23

Normal challenges to pay loans and raise capital
Innovative
Some uniques
Differentiated customer and product portfolio
Traumtanz 
23.11.23 50%
sell
Moderna Inc.

Start price
Target price
Perf. (%)
€70.63
21.11.23
€74.00
21.11.24
0.45%
23.11.23

Normal challenges to pay loans and raise capital
Innovative
Some uniques
Differentiated customer and product portfolio
Traumtanz 
21.11.23 50%
buy
Moderna Inc.

Start price
Target price
Perf. (%)
€72.57
20.11.23
€74.00
20.11.24
-2.67%
21.11.23

Normal challenges to pay loans and raise capital
Innovative
Some uniques
Differentiated customer and product portfolio
Traumtanz 
20.11.23 50%
buy
Moderna Inc.

Start price
Target price
Perf. (%)
€69.64
31.10.23
€71.00
31.10.24
4.21%
20.11.23

Normal challenges to pay loans and raise capital
Innovative
Some uniques
Differentiated customer and product portfolio
Traumtanz 
31.10.23 50%
buy
Moderna Inc.

Start price
Target price
Perf. (%)
€183.12
18.01.23
€110.00
18.01.24
-61.97%
31.10.23

Normal challenges to pay loans and raise capital
Innovative
Some uniques
Differentiated customer and product portfolio
Traumtanz 
18.01.23 50%
buy
Moderna Inc.

Start price
Target price
Perf. (%)
€172.00
10.01.23
€180.00
10.01.24
6.47%
18.01.23

Normal challenges to pay loans and raise capital
Innovative
Some uniques
Differentiated customer and product portfolio
Traumtanz 
10.01.23 50%
buy
Moderna Inc.

Start price
Target price
Perf. (%)
€164.38
14.11.22
€175.00
14.11.23
9.00%
16.11.22

Normal challenges to pay loans and raise capital
Innovative
Some uniques
Differentiated customer and product portfolio
Traumtanz 
14.11.22 50%
buy
Moderna Inc.

Start price
Target price
Perf. (%)
€127.18
05.12.20
€130.00
2.20%
07.12.20

Normal challenges to pay loans and raise capital
Innovative
Some uniques
Differentiated customer and product portfolio
Traumtanz 
05.12.20 50%
buy
Moderna Inc.

Start price
Target price
Perf. (%)
€93.50
26.11.20
€100.00
12.81%
27.11.20

Normal challenges to pay loans and raise capital
Innovative
Some uniques
Differentiated customer and product portfolio
Traumtanz 
26.11.20 50%
buy
Moderna Inc.

Start price
Target price
Perf. (%)
€54.99
03.06.20
€60.00
04.06.20
-4.40%
04.06.20

Normal challenges to pay loans and raise capital
Innovative
Some uniques
Differentiated customer and product portfolio
Traumtanz 
03.06.20 50%
buy
Moderna Inc.

Start price
Target price
Perf. (%)
€58.34
15.05.20
€85.00
27.05.20
-4.61%
27.05.20

Normal challenges to pay loans and raise capital
Innovative
Some uniques
Differentiated customer and product portfolio
Traumtanz 
15.05.20 50%
buy
Moderna Inc.

Start price
Target price
Perf. (%)
€44.00
03.05.20
€70.00
14.05.20
33.00%
14.05.20

Normal challenges to pay loans and raise capital
Innovative
Some uniques
Differentiated customer and product portfolio
Traumtanz 
03.05.20 50%
buy
Moderna Inc.

Start price
Target price
Perf. (%)
€37.43
16.04.20
€50.00
21.04.20
32.71%
21.04.20

Normal challenges to pay loans and raise capital
Innovative
Some uniques
Differentiated customer and product portfolio
Traumtanz 
16.04.20 50%